NO20085423L - stabil formulering omfattende fuktighetsfolsomt legemiddel og fremgangsmate for fremstilling derav - Google Patents

stabil formulering omfattende fuktighetsfolsomt legemiddel og fremgangsmate for fremstilling derav

Info

Publication number
NO20085423L
NO20085423L NO20085423A NO20085423A NO20085423L NO 20085423 L NO20085423 L NO 20085423L NO 20085423 A NO20085423 A NO 20085423A NO 20085423 A NO20085423 A NO 20085423A NO 20085423 L NO20085423 L NO 20085423L
Authority
NO
Norway
Prior art keywords
preparation
stable formulation
pharmaceutical
moisturizing
drug
Prior art date
Application number
NO20085423A
Other languages
English (en)
Norwegian (no)
Inventor
Michael Fox
Original Assignee
Teva Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharma filed Critical Teva Pharma
Publication of NO20085423L publication Critical patent/NO20085423L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
NO20085423A 2006-06-02 2008-12-30 stabil formulering omfattende fuktighetsfolsomt legemiddel og fremgangsmate for fremstilling derav NO20085423L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2006/021586 WO2007142628A1 (en) 2006-06-02 2006-06-02 Stable formulation comprising moisture sensitive drug/s and manufacturing procedure thereof

Publications (1)

Publication Number Publication Date
NO20085423L true NO20085423L (no) 2009-02-25

Family

ID=37607178

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20085423A NO20085423L (no) 2006-06-02 2008-12-30 stabil formulering omfattende fuktighetsfolsomt legemiddel og fremgangsmate for fremstilling derav

Country Status (8)

Country Link
JP (1) JP2009538905A (pt)
CN (1) CN101460191A (pt)
BR (1) BRPI0621739A2 (pt)
CA (1) CA2652620A1 (pt)
IL (1) IL195060A0 (pt)
MX (1) MX2008015343A (pt)
NO (1) NO20085423L (pt)
WO (1) WO2007142628A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102008020701A1 (de) 2008-04-24 2009-10-29 Bayer Technology Services Gmbh Formulierung mit reduzierter Hygroskopizität
US20150094345A1 (en) * 2012-02-17 2015-04-02 Egis Gyogyszergyar Zrt. Pharmaceutical formulation having improved stability
FR2991179B1 (fr) * 2012-06-01 2016-11-11 Ceva Sante Animale Compositions veterinaires orales appetentes

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3739690A1 (de) * 1987-11-24 1989-06-08 Hoechst Ag Stabilisierte arzneistoffe, verfahren zu ihrer herstellung sowie stabile arzneizubereitungen
DE19952030A1 (de) * 1999-10-28 2001-05-03 Basf Ag Verfahren zur Herstellung von hochreaktiven Polyisobutenen
AU2003217916A1 (en) * 2002-03-08 2003-09-22 Teva Pharmeceuticals Usa, Inc. Stable formulations of angiotensin converting enzyme (ace) inhibitors
US6869963B2 (en) * 2003-07-11 2005-03-22 Sandoz Ag Stable pharmaceutical compositions containing an ACE inhibitor
PE20060003A1 (es) * 2004-03-12 2006-03-01 Smithkline Beecham Plc Formulacion farmaceutica polimerica para moldear por inyeccion

Also Published As

Publication number Publication date
CA2652620A1 (en) 2007-12-13
JP2009538905A (ja) 2009-11-12
IL195060A0 (en) 2011-08-01
WO2007142628A1 (en) 2007-12-13
MX2008015343A (es) 2008-12-16
BRPI0621739A2 (pt) 2011-12-20
CN101460191A (zh) 2009-06-17

Similar Documents

Publication Publication Date Title
DE602006014990D1 (de) Intranasale verabreichung von schnell wirkendem insulin
NO20062504L (no) Sammensetninger og doseringsformer for forbedret absorpsjon
NO20042161L (no) Inhibitorer av 11-beta-hydroksysteroid dehydrogenase type 1
NO20080164L (no) N-(pyridin-2-yl)-sulfonamidderivater
NO20080220L (no) Formuleringer med hoy medikament belastning og doseringsformer
NO20082159L (no) Triazolopyridinderivater som inhibitorer av lipaser og fosfolipaser
NO20080827L (no) Faste doseringsformuleringer av narkotiske legemidler som har forbedret bukal adsorpsjon
UA95199C2 (en) Aqueous formulation of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid
NO20081942L (no) Karbamoylbenzotriazolderivater som inhibitorer av lipaser og fosfolipaser
NO20081878L (no) Diacylindazolderivater som lipase- og fosfolipaseinhibitorer
NO20042596L (no) Inbibitorer av 11-beta-hydroksy steroid dehydrogenase type 1
DK2451445T3 (da) Fremgangsmåde til at tørre bibw2992, dets salte og faste farmaceutiske formuleringer omfattende denne aktive ingrediens
NO340679B1 (no) Pyridazinonderivativer, farmasøytiske preparater omfattende slike og slike forbindelser og preparater for anvendelse i terapeutisk aktive substanser til behandling og forebygging av sykdommer
NO20073601L (no) Immunresponsmodifikator-skumformuleringer
NO20071074L (no) Substituerte cykliske ureaderivater, fremstilling derav og farmasoytisk anvendelse derav som kinaseinhibitorer
DE602005021770D1 (de) Indol-1-yl-essigsäurederivate
CY1110906T1 (el) Φαρμακευτικη συνθεση για ρινικη χορηγηση φεντανυλης
NO20074933L (no) Farmasoytisk sammensetning som innbefatter et indolylmaleimidderivat
CY1107819T1 (el) Φαρμακευτικη διαμορφωση της ολανζαπινης
WO2007090661A3 (en) Active substance combination comprising azolylcarbinol compounds
BRPI0517792A (pt) macrolonas - quinolonas amino-substituìdas
NO20085423L (no) stabil formulering omfattende fuktighetsfolsomt legemiddel og fremgangsmate for fremstilling derav
CL2009001183A1 (es) Formulación farmacéutica sólida que comprende a) cilostazol, b) 10 a 90% de un almidón pregelatinizado c) uno o más tipos de ingredientes entéricos, y d) un ácido orgánico.
NO20061236L (no) Farmasoytiske sammensetninger og fremgangsmater omfattende kombinasjoner av 2-alkyliden-19-nor-vitamin D derivater og paratyroidhoziiton
NO20080066L (no) Farmasoytiske preparater av mikronisert (4-klorfenyl) [4-(4-pyridylmetyl)ftalazin-1-yl] og salter derav, med umiddelbar frigivelse og hoyt legemiddelinnhold

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application